Table 1. Demographics of study population according to clinical presentation.
| Overall | STEMI | NSTEMI | UAP | SAP | P-value | |
|---|---|---|---|---|---|---|
| N=206 | N=67 | N=50 | N=33 | N=56 | ||
| Baseline characteristic | ||||||
| Age | 62.99±11.01 | 64.60±11.53 | 62.98±12.05 | 63.70±8.57 | 60.66±10.56 | 0.255 |
| Male(N,%) | 156(75.7) | 51(76.1) | 39(78.0) | 24(72.7) | 42(75.0) | 0.955 |
| Smoking(N,%) | 110(53.4) | 41(61.2) | 28(56.0) | 18(54.5) | 23(41.1) | 0.157 |
| BMI(kg/m2) | 24.89±1.48 | 24.67±1.29 | 24.89±1.51 | 24.89±1.73 | 25.16±1.52 | 0.338 |
| Hypertension(N,%) | 130(63.1) | 34(50.7) | 39(78.0) | 20(60.6) | 37(66.1) | 0.024 |
| Diabetes mellitus(N,%) | 72(35.0) | 28(41.8) | 19(38.0) | 12(36.4) | 13(23.2) | 0.171 |
| Dyslipidemia(N,%) | 43(20.9) | 12(17.9) | 15(30.0) | 6(18.2) | 10(17.9) | 0.343 |
| Stroke(N,%) | 16(7.8) | 5(7.5) | 4(8.0) | 2(6.1) | 5(8.9) | 0.969 |
| Medication history | ||||||
| Aspirin(N,%) | 57(44.2) | 10(18.2) | 15(39.5) | 13(81.2) | 19(95.0) | <0.001 |
| Anti-coagulation(N,%) | 143(69.4) | 66(98.5) | 47(94.0) | 19(57.6) | 11(19.6) | <0.001 |
| Statins(N,%) | 204(99.0) | 67(100.0) | 50(100.0) | 32(97.0) | 55(98.2) | 0.393 |
| β-blockers(N,%) | 189(91.7) | 61(91.0) | 45(90.0) | 31(93.9) | 52(92.9) | 0.909 |
| PPI(N,%) | 57(27.7) | 30(44.8) | 21(42.0) | 1(3.0) | 5(8.9) | <0.001 |
| Other characteristics | ||||||
| WBC(×10^9/L) | 7.52±2.76 | 9.44±3.48 | 7.48±1.80 | 6.24±1.56 | 6.03±1.34 | <0.001 |
| Platelet(×10^9/L) | 198.07±53.09 | 206.15±60.67 | 197.82±48.22 | 182.12±44.00 | 198.04±51.56 | 0.210 |
| Fasting blood glucose(mmol/L) | 6.32±2.35 | 7.41±2.88 | 6.34±2.06 | 5.89±2.30 | 5.25±0.98 | <0.001 |
| Serum creatinine(mmol/L) | 76.21±20.66 | 75.23±21.89 | 75.24±16.96 | 82.03±29.35 | 74.82±15.37 | 0.374 |
| NT-proBNP(ng/L) | 931.13±1459.31 | 1449.45±1608.49 | 1250.59±1903.66 | 610.68±710.20 | 216.82±551.75 | <0.001 |
| Lp(a)(mg/L) | 209.30±201.45 | 165.03±149.96 | 240.45±210.04 | 246.94±276.08 | 213.95±193.31 | 0.136 |
| LVEF(%) | 62.08±9.22 | 57.17±9.43 | 63.68±7.62 | 61.31±9.43 | 66.94±7.02 | <0.001 |
Data are expressed as mean ± standard deviation(SD) or number of patients (percentage).
STEMI, ST segment elevation myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; UAP, unstable angina pectoris; SAP, stable angina pectoris; BMI, body mass index; PPI, proton pump inhibitor; WBC, white blood cell; NT-proBNP, N-terminal pro-brain natriuretic peptide; Lp(a), Lipoprotein(a); LVEF, left ventricular ejection fraction.